Parkinsonism and hyperthyroidism.

Suppr

超能文献

作者信息

Lavy S, Marks E S, Abramsky O

出版信息

Eur Neurol. 1974;12(1):20-7. doi: 10.1159/000114600.

DOI:10.1159/000114600

PMID:4414985

Abstract

摘要

相似文献

Parkinsonism and hyperthyroidism.

Eur Neurol. 1974;12(1):20-7. doi: 10.1159/000114600.

[Factors which influence infavourably l-dopa treatment].[对左旋多巴治疗产生不利影响的因素]

Tidsskr Nor Laegeforen. 1973 Oct 10;93(28):2115-6.

[Attempt at treating parkinsonism with L-dopa and Artane].[左旋多巴与安坦治疗帕金森病的尝试]

Pol Tyg Lek. 1971 Aug 23;26(34):1325-6.

[Present-day treatment of parkinsonism in the aged].[老年人帕金森病的现代治疗]

Schweiz Rundsch Med Prax. 1973 Oct 2;62(40):1202-3.

Psychiatric changes in patients treated with levodopa. I. The clinical experiment.

Neurology. 1970 Dec;20(12):23-30.

Preparation of the thyrotoxic patient for surgery.

Compr Ther. 1980 Aug;6(8):26-32.

Propranolol in the surgical management of thyrotoxicosis.普萘洛尔在甲状腺毒症手术治疗中的应用

Taiwan Yi Xue Hui Za Zhi. 1977 Nov;76(11):857-63.

Treatment of hyperthyroidism. Panel discussion.甲状腺功能亢进症的治疗。小组讨论。

Postgrad Med. 1975 Jun;57(7):84-90. doi: 10.1080/00325481.1975.11714075.

Letter: Levodopa-propranolol therapy in parkinsonian tremor.信函：左旋多巴-普萘洛尔疗法治疗帕金森震颤

Lancet. 1974 Mar 9;1(7854):403-4. doi: 10.1016/s0140-6736(74)93165-1.

Parkinsonism and dopa.

N Z Med J. 1969 May;69(444):306-7.

引用本文的文献

Thyroid Disorders and Movement Disorders-A Systematic Review.甲状腺疾病与运动障碍——一项系统评价

Mov Disord Clin Pract. 2023 Feb 3;10(3):360-368. doi: 10.1002/mdc3.13656. eCollection 2023 Mar.

Association between hyperthyroidism and risk of incident in Parkinson's disease.甲状腺功能亢进与帕金森病发病风险之间的关联。

Endocr Connect. 2021 Jan;10(1):13-20. doi: 10.1530/EC-20-0554.

A Rationally Designed TNF-α Epitope-Scaffold Immunogen Induces Sustained Antibody Response and Alleviates Collagen-Induced Arthritis in Mice.一种合理设计的肿瘤坏死因子-α表位支架免疫原可诱导持续抗体反应并减轻小鼠胶原诱导的关节炎。

PLoS One. 2016 Sep 22;11(9):e0163080. doi: 10.1371/journal.pone.0163080. eCollection 2016.

The role of Thyrotropin Releasing Hormone in aging and neurodegenerative diseases.促甲状腺激素释放激素在衰老和神经退行性疾病中的作用。

Am J Alzheimers Dis (Columbia). 2013;1(1). doi: 10.7726/ajad.2013.1003.

Levodopa-induced dyskinesia is associated with increased thyrotropin releasing hormone in the dorsal striatum of hemi-parkinsonian rats.左旋多巴诱导的运动障碍与半帕金森病大鼠背侧纹状体中促甲状腺素释放激素的增加有关。

PLoS One. 2010 Nov 10;5(11):e13861. doi: 10.1371/journal.pone.0013861.

Graves' disease presenting as hemiparkinsonism.以偏侧帕金森综合征为表现的格雷夫斯病

J Endocrinol Invest. 2001 Mar;24(3):188-9. doi: 10.1007/BF03343841.

Resolution of dyskinesia and the "on-off" phenomenon in thyrotoxic patients with Parkinson's disease after antithyroid treatment.抗甲状腺治疗后帕金森病合并甲状腺毒症患者运动障碍及“开-关”现象的缓解

Br Med J (Clin Res Ed). 1986 Jul 5;293(6538):38-9. doi: 10.1136/bmj.293.6538.38.

Ultrasensitive TSH assay and anti-parkinsonian treatment with levodopa.超敏促甲状腺激素检测与左旋多巴抗帕金森病治疗

J Neurol Neurosurg Psychiatry. 1992 Dec;55(12):1210-1. doi: 10.1136/jnnp.55.12.1210-a.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验